Table of Content
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CANCER BIOPSY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Product
3.7.2 By Type
3.7.3 By Application
3.7.4 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY PRODUCT
6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Instruments Market by Regions
6.6 Kits and Consumables Market by Regions
6.5 Services Market by Regions
7 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY TYPE
7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Regions
7.5 Liquid Biopsies Market by Regions
7.6 Others Market by Regions
8 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY APPLICATION
8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Breast Cancer Market by Regions
8.5 Colorectal Cancer Market by Regions
8.6 Cervical Cancers Market by Regions
8.7 Lung Cancers Market by Regions
8.8 Prostate Cancers Market by Regions
8.9 Skin Cancers Market by Regions
8.10. Blood Cancers Market by Regions
8.11 Kidney Cancers Market by Regions
8.12 Liver Cancers Market by Regions
8.13 Pancreatic Cancers Market by Regions
8.14 Ovarian Cancers Market by Regions
9 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa
10 . COMPETITIVE LANDSCAPE OF THE CANCER BIOPSY COMPANIES
10.1. Cancer Biopsy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF CANCER BIOPSY INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Qiagen N.V.
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. GRAIL, Inc
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Illumina, Inc.
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. ANGLE Plc
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. BD (Becton, Dickinson And Company)
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Myriad Genetics
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Hologic, Inc.
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Biocept, Inc.
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Thermo Fisher Scientific, Inc.
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Danaher
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
11.13. F. Hoffmann-La Roche Ltd.
11.13.1. Company Overview
11.13.2. Financials
11.13.3. Products
11.13.4. Recent Developments
11.14. Lucence Diagnostics Pte. Ltd.
11.14.1. Company Overview
11.14.2. Financials
11.14.3. Products
11.14.4. Recent Developments
11.15. Guardant Health
11.15.1. Company Overview
11.15.2. Financials
11.15.3. Products
11.15.4. Recent Developments
11.16. Exact Sciences Corporation
11.16.1. Company Overview
11.16.2. Financials
11.16.3. Products
11.16.4. Recent Developments
11.17. Biodesix (Integrated Diagnostics)
11.17.1. Company Overview
11.17.2. Financials
11.17.3. Products
11.17.4. Recent Developments
11.18. Freenome Holdings, Inc.
11.18.1. Company Overview
11.18.2. Financials
11.18.3. Products
11.18.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
COVID-19 Impact Analysis by Production, Import, Export and Demand
Pre V/S Post COVID-19
Estimated Impact Of The Coronavirus (Covid-19) Epidemic
COVID-19: Micro and Macro Factor Analysis
Analysis by Product (USD MN)
Instruments Market by Geography (USD MN)
Kits and Consumables Market by Geography (USD MN)
Services Market by Geography (USD MN)
Analysis Market by Type (USD MN)
Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
Liquid Biopsies Market by Geography (USD MN)
Others Market by Geography (USD MN)
Analysis by Application (USD MN)
Breast Cancer Market by Geography (USD MN)
Colorectal Cancer Market by Geography (USD MN)
Cervical Cancers Market by Geography (USD MN)
Lung Cancers Market by Geography (USD MN)
Prostate Cancers Market by Geography (USD MN)
Skin Cancers Market by Geography (USD MN)
Blood Cancers Market by Geography (USD MN)
Kidney Cancers Market by Geography (USD MN)
Liver Cancers Market by Geography (USD MN)
Pancreatic Cancers Market by Geography (USD MN)
Ovarian Cancers Market by Geography (USD MN)
Global Cancer Biopsy Market by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisiton
LIST OF FIGURES
Research Scope of Cancer Biopsy Report
Market Research Process
Market Research Methodology
Global Cancer Biopsy Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product (USD MN)
Instruments Market by Geography (USD MN)
Kits and Consumables Market by Geography (USD MN)
Services Market by Geography (USD MN)
Global Market Analysis by Type (USD MN)
Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
Liquid Biopsies Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Breast Cancer Market by Geography (USD MN)
Colorectal Cancer Market by Geography (USD MN)
Cervical Cancers Market by Geography (USD MN)
Lung Cancers Market by Geography (USD MN)
Prostate Cancers Market by Geography (USD MN)
Skin Cancers Market by Geography (USD MN)
Blood Cancers Market by Geography (USD MN)
Kidney Cancers Market by Geography (USD MN)
Liver Cancers Market by Geography (USD MN)
Pancreatic Cancers Market by Geography (USD MN)
Ovarian Cancers Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis, 2019
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.